OraSure Technologies | OSUR - 债务



金融业
股票价格
USD
资产
USD 403.17M
现金及等价物
USD 199.28M
销售成本
USD 15.43M
流动资产
USD 261.91M
流动负债
USD 39.8M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 340.83M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 217.7M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 31.06M
贸易债权人
USD 6.52M
应收帐款人
USD 22.2M


债务 更改 日
Agilent USD 3.35B 55M 2025-09
AngioDynamics USD 6.3M 6.3M 2025-02
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Bio Techne USD 260M 40M 2025-12
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Bruker USD 2.01B 426.8M 2025-09
Cerus USD 84.16M 791K 2024-12
Charles River Laboratories USD 2.63B 157.4M 2025-09
Danaher USD 18.48B 66M 2026-03
Dentsply International USD 2.47B 12M 2025-12
Dexcom USD 1.24B 900K 2026-03
Illumina USD 2.55B 23M 2025-12
Integra LifeSciences USD 2.03B 27.32M 2025-12
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 15.83B 109M 2026-03
Mesa Laboratories USD 204.98M 7.27M 2024-09
Mettler Toledo International USD 2.21B 25.94M 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
OraSure Technologies USD 782K 465K 2024-06
Quidel USD 2.83B 9.9M 2025-12
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 3.4B 29.2M 2025-12
STAAR Surgical USD 39.12M 1.4M 2025-09
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Trinity Biotech USD 100.76M 7.05M 2024-12
Waters USD 1.49B 4.92M 2025-12